180 related articles for article (PubMed ID: 24018922)
21. Characterisation of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typing.
Walker AS; Eyre DW; Wyllie DH; Dingle KE; Harding RM; O'Connor L; Griffiths D; Vaughan A; Finney J; Wilcox MH; Crook DW; Peto TE
PLoS Med; 2012 Feb; 9(2):e1001172. PubMed ID: 22346738
[TBL] [Abstract][Full Text] [Related]
22. Implementing automated surveillance for tracking Clostridium difficile infection at multiple healthcare facilities.
Dubberke ER; Nyazee HA; Yokoe DS; Mayer J; Stevenson KB; Mangino JE; Khan YM; Fraser VJ
Infect Control Hosp Epidemiol; 2012 Mar; 33(3):305-8. PubMed ID: 22314071
[TBL] [Abstract][Full Text] [Related]
23. Increasing incidence of Clostridium difficile ribotype 001 associated with severe course of the infection and previous fluoroquinolone use in the Czech Republic, 2015.
Krutova M; Matejkova J; Drevinek P; Kuijper EJ; Nyc O;
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2251-2258. PubMed ID: 28681203
[TBL] [Abstract][Full Text] [Related]
24. Population-based surveillance of Clostridium difficile infection in Manitoba, Canada, by using interim surveillance definitions.
Lambert PJ; Dyck M; Thompson LH; Hammond GW
Infect Control Hosp Epidemiol; 2009 Oct; 30(10):945-51. PubMed ID: 19732008
[TBL] [Abstract][Full Text] [Related]
25. Multipronged intervention strategy to control an outbreak of Clostridium difficile infection (CDI) and its impact on the rates of CDI from 2002 to 2007.
Weiss K; Boisvert A; Chagnon M; Duchesne C; Habash S; Lepage Y; Letourneau J; Raty J; Savoie M
Infect Control Hosp Epidemiol; 2009 Feb; 30(2):156-62. PubMed ID: 19125681
[TBL] [Abstract][Full Text] [Related]
26. Assessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005.
Kutty PK; Benoit SR; Woods CW; Sena AC; Naggie S; Frederick J; Engemann J; Evans S; Pien BC; Banerjee SN; Engel J; McDonald LC
Infect Control Hosp Epidemiol; 2008 Mar; 29(3):197-202. PubMed ID: 18241032
[TBL] [Abstract][Full Text] [Related]
27. Healthcare facility-onset, healthcare facility-associated
Evans CT; Fitzpatrick M; Ramanathan S; Kralovic SM; Burns SP; Goldstein B; Smith B; Gerding DN; Johnson S
J Spinal Cord Med; 2020 Sep; 43(5):642-652. PubMed ID: 31663843
[No Abstract] [Full Text] [Related]
28. Clostridium difficile infection in an Iranian hospital.
Jalali M; Khorvash F; Warriner K; Weese JS
BMC Res Notes; 2012 Mar; 5():159. PubMed ID: 22436392
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant vancomycin for antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery.
Bateman BT; Rassen JA; Schneeweiss S; Bykov K; Franklin JM; Gagne JJ; Polinski JM; Liu J; Kulik A; Fischer MA; Choudhry NK
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):472-8. PubMed ID: 23541855
[TBL] [Abstract][Full Text] [Related]
30. Increasing incidence of Clostridium difficile infection, Australia, 2011-2012.
Slimings C; Armstrong P; Beckingham WD; Bull AL; Hall L; Kennedy KJ; Marquess J; McCann R; Menzies A; Mitchell BG; Richards MJ; Smollen PC; Tracey L; Wilkinson IJ; Wilson FL; Worth LJ; Riley TV
Med J Aust; 2014 Mar; 200(5):272-6. PubMed ID: 24641152
[TBL] [Abstract][Full Text] [Related]
31. Clostridium difficile infection in the intensive care unit.
Riddle DJ; Dubberke ER
Infect Dis Clin North Am; 2009 Sep; 23(3):727-43. PubMed ID: 19665092
[TBL] [Abstract][Full Text] [Related]
32. Identification of a pseudo-outbreak of Clostridium difficile infection (CDI) and the effect of repeated testing, sensitivity, and specificity on perceived prevalence of CDI.
Litvin M; Reske KA; Mayfield J; McMullen KM; Georgantopoulos P; Copper S; Hoppe-Bauer JE; Fraser VJ; Warren DK; Dubberke ER
Infect Control Hosp Epidemiol; 2009 Dec; 30(12):1166-71. PubMed ID: 19848606
[TBL] [Abstract][Full Text] [Related]
33. An agent-based simulation model for Clostridium difficile infection control.
Codella J; Safdar N; Heffernan R; Alagoz O
Med Decis Making; 2015 Feb; 35(2):211-29. PubMed ID: 25112595
[TBL] [Abstract][Full Text] [Related]
34. Trends in the use of laboratory tests for the diagnosis of Clostridium difficile infection and association with incidence rates in Quebec, Canada, 2010-2014.
Bogaty C; Lévesque S; Garenc C; Frenette C; Bolduc D; Galarneau LA; Lalancette C; Loo V; Tremblay C; Trudeau M; Vachon J; Dionne M; Villeneuve J; Longtin J; Longtin Y;
Am J Infect Control; 2017 Sep; 45(9):964-968. PubMed ID: 28549882
[TBL] [Abstract][Full Text] [Related]
35. Hospital-based Clostridium difficile infection surveillance reveals high proportions of PCR ribotypes 027 and 176 in different areas of Poland, 2011 to 2013.
Pituch H; Obuch-Woszczatyński P; Lachowicz D; Wultańska D; Karpiński P; Młynarczyk G; van Dorp SM; Kuijper EJ;
Euro Surveill; 2015; 20(38):. PubMed ID: 26536049
[TBL] [Abstract][Full Text] [Related]
36. CDC's Hospital-Onset Clostridioides difficile Prevention Framework in a Regional Hospital Network.
Turner NA; Krishnan J; Nelson A; Polage CR; Sinkowitz-Cochran RL; Fike L; Kuhar DT; Kutty PK; Snyder RL; Anderson DJ
JAMA Netw Open; 2024 Mar; 7(3):e243846. PubMed ID: 38536174
[TBL] [Abstract][Full Text] [Related]
37. Impact of PCR testing for Clostridium difficile on incident rates and potential on public reporting: is the playing field level?
Fong KS; Fatica C; Hall G; Procop G; Schindler S; Gordon SM; Fraser TG
Infect Control Hosp Epidemiol; 2011 Sep; 32(9):932-3. PubMed ID: 21828981
[No Abstract] [Full Text] [Related]
38. Assessment of Federal Value-Based Incentive Programs and In-Hospital Clostridioides difficile Infection Rates.
Alrawashdeh M; Rhee C; Hsu H; Wang R; Horan K; Lee GM
JAMA Netw Open; 2021 Oct; 4(10):e2132114. PubMed ID: 34714336
[TBL] [Abstract][Full Text] [Related]
39. A Comprehensive Assessment Across the Healthcare Continuum: Risk of Hospital-Associated Clostridium difficile Infection Due to Outpatient and Inpatient Antibiotic Exposure.
Tartof SY; Rieg GK; Wei R; Tseng HF; Jacobsen SJ; Yu KC
Infect Control Hosp Epidemiol; 2015 Dec; 36(12):1409-16. PubMed ID: 26387888
[TBL] [Abstract][Full Text] [Related]
40. Severe Clostridium difficile infection: incidence and risk factors at a tertiary care university hospital in Vienna, Austria.
Starzengruber P; Segagni Lusignani L; Wrba T; Mitteregger D; Indra A; Graninger W; Presterl E; Diab-Elschahawi M
Wien Klin Wochenschr; 2014 Jul; 126(13-14):427-30. PubMed ID: 24903143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
